// App-Quantinova.ai

: COMBINATION OF AN ANTAGONIST TO THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN WITH ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION RESISTANT PROSTATE CANCER

Researchers

Presenter

  • Yukiyoshi Hirayama

Principal Investigators

  • Kunzhong Jian

  • Raymond J. Anderson

  • Marianne D. Sadar

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Androgen receptor variant 7

Drug/Treatment

  • Enzalutamide

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved